Literature DB >> 26963802

Treatment of atrophic facial acne scars with fractional Er:YAG laser in skin phototype III-IV: A pilot study.

Alireza Firooz1, Ali Rajabi-Estarabadi1, Mohammad Hassan Nassiri-Kashani1.   

Abstract

BACKGROUND: Fractional ablative lasers have recently been used for the treatment of skin scars. The objective of this study was to assess the efficacy and safety of the fractional erbium-doped yttrium aluminum garnet (Er:YAG) laser (2940 nm) in the treatment of skin scars.
MATERIALS AND METHODS: A total of 9 patients (8 female, 1 male) with Fitzpatrick skin types III and IV suffering from atrophic facial acne scars were treated with a fractional Er:YAG laser for 2-5 (mean 3.3) sessions 4-6 weeks apart. One independent investigator assessed the efficacy, using standardized photographs, before and 1 month after the last treatment. The patients' satisfaction rate was also evaluated.
RESULTS: The treatment was well tolerated by all patients without any anesthesia. The downtime was 2-3 days. All patients showed improvement in scars: excellent in 1, good in 1, and fair in 7 patients. Six patients were highly satisfied and 3 were satisfied with treatment. No adverse effect was noted.
CONCLUSION: A fractional Er:YAG laser can deliver an effective and minimally invasive treatment for acne scars.

Entities:  

Keywords:  Atrophic acne scar; Er; YAG; fractional ablative lasers; laser; skin phototype

Mesh:

Year:  2016        PMID: 26963802     DOI: 10.3109/14764172.2016.1157354

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  2 in total

1.  Fractional Erbium-YAG Laser and Platelet-Rich Plasma as Single or Combined Treatment for Atrophic Acne Scars: A Randomized Clinical Trial.

Authors:  Moustafa A El-Taieb; Hassan M Ibrahim; Eisa M Hegazy; Ahmed K Ibrahim; Aya M Gamal; Essam A Nada
Journal:  Dermatol Ther (Heidelb)       Date:  2019-08-16

2.  Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: a prospective, simultaneous spilt-face clinical trial.

Authors:  Kune Lu; Suiqing Cai
Journal:  Lasers Med Sci       Date:  2021-11-26       Impact factor: 3.161

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.